Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for ImageneBio, Inc. COMMON STOCK (IMA).
- Disclosed ownership: 13%.
- Date of event: 14 Apr 2026.
ORBIMED ADVISORS LLC - 14 Apr 2026 SCHEDULE 13D/A Report for ImageneBio, Inc. COMMON STOCK (IMA)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Security
- ImageneBio, Inc. COMMON STOCK
- Symbol
- IMA
- Shares outstanding
- 11,412,557 shares
- Disclosed Ownership
- 1,495,045 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13D/A
- Filing time
- 29 Apr 2026, 19:07:16 UTC
- Date of event
- 14 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 13% ownership in ImageneBio, Inc. COMMON STOCK (IMA) on 14 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Apr 2026, 19:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 13% | 1,495,045 | 0 | 1,495,045 | /s/ Carl L. Gordon | Carl L. Gordon, Member | 0001055951 |
| ORBIMED CAPITAL GP VI LLC | 9.6% | 1,089,665 | 0 | 1,089,665 | /s/ Carl L. Gordon | Carl L. Gordon, Member of OrbiMed Advisors LLC | 0001682115 |
| OrbiMed Genesis GP LLC | 3.6% | 405,380 | 0 | 405,380 | /s/ Carl L. Gordon | Carl L. Gordon, Member of OrbiMed Advisors LLC | 0001808744 |
| ORBIMED CAPITAL LLC | 1.2% | 135,516 | 135,516 | 0 | /s/ Carl L. Gordon | Carl L. Gordon, Member | 0001157524 |